Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06427954 · ClinicalTrials.gov registry record · NA
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
A NA study of Lung Cancer, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 3
- Study locations
NCT06427954: Recruiting NA study of Lung Cancer, sponsored by Massachusetts General Hospital.
NCT06427954 is a NA study of Lung Cancer that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 250 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06427954, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 3
- Study locations
Study Summary
Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.
Primary Outcome
Quality of Life (higher scores indicate better quality of life)
Conditions Studied
Interventions
- BEHAVIORAL Digital Health App
Study Locations (3)
California
- University of California Los Angeles - Los Angeles
- Veteran Affairs Greater Los Angeles Health Care - Los Angeles
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-08-06 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06427954 shows while recruiting
NCT06427954 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Digital Health App is the first listed.
NCT06427954 reports a single indexed study location in California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06427954 about?
NCT06427954 is a clinical study titled "Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer". Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.
What is the current status of trial NCT06427954?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-08-06. Estimated completion is 2027-12.
What conditions does trial NCT06427954 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT06427954?
The interventions under investigation include: Digital Health App (BEHAVIORAL).
Who is sponsoring clinical trial NCT06427954?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06427954 being conducted?
This trial has 3 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06427954's enrollment target sits among peer trials
250 112th of 409 higher than 296 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI